Introduction and Executive Summary The United States runs the by far biggest and most bloated healthcare sector in the world when measured as a share of the total economy. Its annual value was $3.7 trillion, amounting to 17.9% of GDP (2018). That is nearly double the average of developed Western countries (as a share of…
USAID has just awarded $160 million to the United States Pharmacopeia (USP) for a cooperative agreement to regulate the pharmaceutical landscape in Africa. U.S. taxpayers are now funding a U.S. State Department approved plan developed so our government can help big pharma pimps. Here’s a look inside USP and this latest USAID plan. Pharma Pimps…
The pharmaceutical industry is holding on to its title as the top lobbying force in Washington amid pressure from lawmakers at all ends of the ideological spectrum. Drugmakers have spent more than $129 million through September, slightly down from nearly $133 million at this time last year, but still far more than any other industry. …
This new year will likely mark another milestone in science and medicine. Again, Americans will spend more money on diagnostic tests, surgeries and other medical procedures, and patients will consume more drugs and receive more treatments than any other time in US history. We will continue to be inundated with television drug advertisements with the…
“In 1986 a US law was passed that protected vaccine maker’s from ever being sued in a a regular court regardless of how many babies or children were injured of killed from the aluminum, mercury (aka Thimerosal), formaldehyde, aborted fetal cells, deadly peanut byproducts, cells of pigs, cows, monkeys, dogs, insects, MSG (monosodium glutamate), ether…
The Trump administration has proposed that insurance plans providing drug coverage to Medicare beneficiaries will no longer be forced to cover six hitherto “protected” drug classes. The classes––which include drugs for psychiatric conditions, cancer and immune diseases––are among the priciest of all drugs and account for as much as 33 percent of total outpatient drug…
